Annual Shareholders Equity
$85.08 M
-$15.51 M-15.42%
December 31, 2023
Summary
- As of February 12, 2025, QNCX annual stockholders equity is $85.08 million, with the most recent change of -$15.51 million (-15.42%) on December 31, 2023.
- During the last 3 years, QNCX annual shareholders equity has fallen by -$87.18 million (-50.61%).
- QNCX annual shareholders equity is now -50.61% below its all-time high of $172.26 million, reached on December 31, 2020.
Performance
QNCX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$44.93 M
-$2.04 M-4.33%
September 30, 2024
Summary
- As of February 12, 2025, QNCX quarterly stockholders equity is $44.93 million, with the most recent change of -$2.04 million (-4.33%) on September 30, 2024.
- Over the past year, QNCX quarterly shareholders equity has dropped by -$40.15 million (-47.19%).
- QNCX quarterly shareholders equity is now -79.39% below its all-time high of $218.04 million, reached on March 31, 2020.
Performance
QNCX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
QNCX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.4% | -47.2% |
| 3 y3 years | -50.6% | -47.2% |
| 5 y5 years | +360.8% | -47.2% |
QNCX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -28.3% | at low | -62.1% | at low |
| 5 y | 5-year | -50.6% | at low | -79.4% | at low |
| alltime | all time | -50.6% | +360.8% | -79.4% | +218.2% |
Quince Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $44.93 M(-4.3%) |
| Jun 2024 | - | $46.97 M(-36.7%) |
| Mar 2024 | - | $74.18 M(-12.8%) |
| Dec 2023 | $85.08 M(-15.4%) | $85.08 M(+2.3%) |
| Sep 2023 | - | $83.13 M(-4.3%) |
| Jun 2023 | - | $86.88 M(-3.7%) |
| Mar 2023 | - | $90.20 M(-10.3%) |
| Dec 2022 | $100.59 M(-15.2%) | $100.59 M(-3.8%) |
| Sep 2022 | - | $104.53 M(-6.3%) |
| Jun 2022 | - | $111.53 M(+4.8%) |
| Mar 2022 | - | $106.38 M(-10.3%) |
| Dec 2021 | $118.59 M | $118.59 M(-10.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $132.65 M(-6.6%) |
| Jun 2021 | - | $142.08 M(-9.2%) |
| Mar 2021 | - | $156.48 M(-9.2%) |
| Dec 2020 | $172.26 M(+49.2%) | $172.26 M(-8.4%) |
| Sep 2020 | - | $188.01 M(-8.5%) |
| Jun 2020 | - | $205.47 M(-5.8%) |
| Mar 2020 | - | $218.04 M(+88.8%) |
| Dec 2019 | $115.48 M(-453.9%) | $115.48 M(-9.3%) |
| Sep 2019 | - | $127.29 M(-6.6%) |
| Jun 2019 | - | $136.22 M(-458.2%) |
| Mar 2019 | - | -$38.03 M(+16.6%) |
| Dec 2018 | -$32.63 M(+60.9%) | -$32.63 M |
| Dec 2017 | -$20.28 M | - |
FAQ
- What is Quince Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Quince Therapeutics?
- What is Quince Therapeutics annual shareholders equity year-on-year change?
- What is Quince Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Quince Therapeutics?
- What is Quince Therapeutics quarterly shareholders equity year-on-year change?
What is Quince Therapeutics annual stockholders equity?
The current annual shareholders equity of QNCX is $85.08 M
What is the all time high annual shareholders equity for Quince Therapeutics?
Quince Therapeutics all-time high annual stockholders equity is $172.26 M
What is Quince Therapeutics annual shareholders equity year-on-year change?
Over the past year, QNCX annual stockholders equity has changed by -$15.51 M (-15.42%)
What is Quince Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of QNCX is $44.93 M
What is the all time high quarterly shareholders equity for Quince Therapeutics?
Quince Therapeutics all-time high quarterly stockholders equity is $218.04 M
What is Quince Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, QNCX quarterly stockholders equity has changed by -$40.15 M (-47.19%)